Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
10+ hour, 51+ min ago (338+ words) Results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, South Korea (abstract #PL03.08). In the primary endpoint of PFS, Enhertu monotherapy…...
Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy
11+ hour, 47+ min ago (739+ words) PR Newswire SHANGHAI and HONG KONG, Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies…...
Cancer plan is only first step
7+ hour, 44+ min ago (413+ words) September is Blood Cancer Awareness Month, and as part of our Let’s talk lymphoma campaign, Lymphoma Action is inviting people affected by lymphoma to write to their MP, MSP or MS and ask them to raise important issues about lymphoma…...
TAGRISSO?? (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
11+ hour, 51+ min ago (605+ words) Longest survival data ever reported in a global Phase III trial in this setting New data reinforce TAGRISSO as the standard of care and backbone therapy in EGFRm lung cancer across stages These results were presented today during the Presidential…...
Breast cancer medicine may increase fibroid risk: Know the precautions needed during treatment and ways to reduce breast cancer risk
16+ hour, 43+ min ago (35+ words) Know the precautions needed during treatment and ways to reduce breast cancer risk Bhaskar English Breast cancer medicine may increase fibroid risk:Know the precautions needed during treatment and ways to reduce breast cancer risk...
Spotlight On: Ivonescimab beats expectations to revive practice-changing hopes in NSCLC
18+ hour, 1+ min ago (13+ words) FirstWord Pharma...
Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible - OncoDaily
22+ hour, 55+ min ago (105+ words) Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible Oncodaily Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible Catharine Grimes, President of the Bristol Myers Squibb Foundation, shared on LinkedIn: “The World Conference on Lung Cancer begins…...
Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
1+ day, 3+ hour ago (171+ words) Sep 13, 2026, 08:54 ET For decades, PCI has been used after initial therapy for SCLC because studies conducted before routine MRI demonstrated that it reduced brain metastases and improved overall survival. MAVERICK was designed to determine whether modern MRI surveillance could allow…...
Miguel Bronchud: A New Molecular Switch in Prostate Cancer Treatment Resistance
23+ hour, 14+ min ago (480+ words) “Prostate cancers – ‘maybe lost in translation’? New hopes for more effective treatments ‘This is the first time anyone’s ever shown that the identity of the cell can be regulated by inhibiting translation’ said at the Fred Hutch Institute in Seattle…...
Professor Jie Wang, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China. [IMAGE] | EurekAlert! Science News Releases
1+ day, 10+ hour ago (74+ words) dijo la profesora Jie Wang, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China. EurekAlert! Professor Jie Wang, National Cancer Center/National Clinical Research Center for Cancer…...